SYNAREL 0.2 mg/dose, solution as a nasal spray bottle, 8 ml
Active ingredients: Nafarelin acetate, Nafarelin
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Solution for sprayingbottle, 8 mlnasale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- SYNAREL 0,2 mg/dose, solution pour pulvérisation nasale
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 1 flacon(s) en verre de 8 ml avec embout nasal polypropylène
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Nov 2000
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63954950CIP73535210CIP133400935352101Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NAFARÉLINE BASEsolution | 0,20 mg · une dose | FT |
| ACÉTATE DE NAFARÉLINEsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.